Astrana Health (ASTH) Debt to Equity (2012 - 2026)

Astrana Health (ASTH) has 15 years of Debt to Equity data on file, last reported at $1.26 in Q1 2026.

• Quarterly Debt to Equity rose 127.19% year-over-year to $1.26 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.26 (up 127.19% YoY) and the FY2025 annual result came in at $1.33, up 119.79% from the prior year.
• Debt to Equity eased to $1.26 in Q1 2026 per ASTH's latest filing, from $1.33 in the prior quarter.
• The five-year high for Debt to Equity was $1.35 in Q3 2025, with the low at $0.35 in Q3 2023.
• Average Debt to Equity over 5 years is $0.63, with a median of $0.54 recorded in 2025.
• Year-over-year, Debt to Equity sank 43.29% in 2022 and jumped 127.19% in 2026.
• Astrana Health's Debt to Equity stood at $0.37 in 2022, then rose by 20.47% to $0.45 in 2023, then surged by 34.31% to $0.61 in 2024, then jumped by 119.79% to $1.33 in 2025, then declined by 5.43% to $1.26 in 2026.
• Business Quant data shows ASTH's Debt to Equity at $1.26 in Q1 2026, $1.33 in Q4 2025, and $1.35 in Q3 2025.